ReShape Lifesciences (RSLS) has received a notice of allowance from for a U.S. patent related to its proprietary diabetes neuromodulation technology. RSLS +20.6 ...

Stimulating either of a pair of crucial nerves that carry messages from the brain to several major organs could be an ...

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in RA.

While early wearables were all about tracking data, this next wave of innovation is focused on solutions to core need states ...

Epilepsy is the fourth most common neurological disorder in the US. In California, more than 427,000 people are living with ...

There is very little known about LGS. Of patients who have been diagnosed withit, 30-35% do not have a known cause.

There are people who suddenly collapse or twitch without any specific cause when they are stressed, standing for a long time, ...

Professor Paul Nwani, the neurologist at the Nnamdi Azikiwe University Teaching Hospital, Nnewi, is the President of the Nigerian League against Epilepsy. In this interview with Sade Oguntola, he ...

Epilepsy, a seizure disorder that affects about 50 million people worldwide, often disrupts memory, emotions and sleep. Many cases are drug-resistant, leaving people with limited treatment options.

Surging Demand for Non-Pharmacological Therapies and Advancements in Neurostimulation Technologies Fuel Market Expansion ...

It has not approved it for depression. The FDA approved vagus nerve stimulation for treatment-resistant depression in adults in 2005. In 2017, it approved the first handheld, noninvasive vagus ...

Background: Stroke is a major global health concern, imposing significant medical and social burdens. Vagus nerve stimulation (VNS), an emerging neuromodulation technology, has shown potential in the ...